Venovenous haemodiafiltration for the management of dabigatran overdose in intensive care unit

Dabigatran is a direct thrombin inhibitor indicated for thromboembolism prophylaxis in patients with non-valvular atrial fibrillation. The procedure to manage dabigatran-associated haemorrhages is not well formalized. Conventional haemodialysis has been evaluated with good results. Patients with dab...

Full description

Saved in:
Bibliographic Details
Published in:Clinical kidney journal Vol. 8; no. 2; pp. 199 - 201
Main Authors: Claisse, Guillaume, Delavenne, Xavier, Masson, Ingrid, Maillard, Nicolas, Alamartine, Eric, Mariat, Christophe
Format: Journal Article
Language:English
Published: England Oxford University Press 01-04-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Dabigatran is a direct thrombin inhibitor indicated for thromboembolism prophylaxis in patients with non-valvular atrial fibrillation. The procedure to manage dabigatran-associated haemorrhages is not well formalized. Conventional haemodialysis has been evaluated with good results. Patients with dabigatran-associated bleeding may be unstable and convective techniques like venovenous haemodiafiltration (HDF) can be interesting. We report the case of a 74-year-old, critically ill patient with haemorrhagic shock and dabigatran overexposure due to acute kidney injury. He underwent HDF and dabigatran blood concentrations decreased from 325.3 ng/mL to 160.5 ng/mL. We report here key pharmacokinetics parameters (half-life, extraction coefficient, clearance).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2048-8505
2048-8513
DOI:10.1093/ckj/sfv001